FDA.reportPublic FDA data

PREZISTA 100 MG in 1 mL Oral Suspension

RxCUI
1236632
RxNorm name
PREZISTA 100 MG in 1 mL Oral Suspension
Display name
PREZISTA 100 MG in 1 mL Oral Suspension
Full name
PREZISTA 100 MG in 1 mL Oral Suspension
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:06

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
PREZISTADARUNAVIRJanssen Products LP814301f9-c990-46a5-b481-2879a521a16f2025-08-29Warnings, Adverse reactionsExact identifier
rxcui: 1236632

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
814301f9-c990-46a5-b481-2879a521a16fPREZISTA 100 MG in 1 mL Oral Suspension [PSN] · darunavir 100 MG/ML Oral Suspension [Prezista] [SBD] · Prezista 100 MG per 1 ML Oral Suspension [SY] · Prezista 100 MG/ML Oral Suspension [SY]458These highlights do not include all the information needed to use PREZISTA safely and effectively. See Full Prescribing Information for PREZISTA. PREZISTA ® (darunavir) oral suspension PREZISTA ® (darunavir) tablet, for oral use Initial U.S. Approval: 200620250829